Hyundai Pharmaceutical Co., Ltd. (KRX:004310)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,680.00
-110.00 (-1.25%)
Last updated: Apr 29, 2026, 11:55 AM KST
152.69%
Market Cap 243.29B
Revenue (ttm) 108.14B
Net Income (ttm) 1.41B
Shares Out 27.68M
EPS (ttm) 60.34
PE Ratio 145.68
Forward PE n/a
Dividend 30.00 (0.33%)
Ex-Dividend Date Mar 3, 2026
Volume 231,110
Average Volume 413,606
Open 8,800.00
Previous Close 8,790.00
Day's Range 8,540.00 - 8,840.00
52-Week Range 3,260.00 - 15,960.00
Beta 0.96
RSI 48.19
Earnings Date n/a

About Hyundai Pharmaceutical

Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilatory, dermatological agent, dermatology, dietary supplements, digestive sy... [Read more]

Sector Healthcare
Founded 1965
Employees 393
Stock Exchange Korea Stock Exchange
Ticker Symbol 004310
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.